The anti-venom Fav-Afrique produced by Sanofi Pasteur will expire without available replacement


A spokesman for Sanofi Pasteur said the pharmaceutical was driven out of the market by competitors selling cheaper products and that they announced in 2010 they would stop making anti-venom. He even ironically revealed: “It’s very strange that (health officials) are only realizing this problem five years later.” Unfortunately, nothing achieved yet to transfer the anti-venom technology to others. About 5 million people are bitten by snakes every year, including 100,000 deaths and several hundred thousand others who suffer amputations or other disabilities. The situation must be solved soon or the price will too many human lives.


Please enter your comment!
Please enter your name here